Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study.
Saved in:
| Title: | Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. |
|---|---|
| Authors: | Pivonello R; Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università Federico II di Napoli, Naples, Italy., Bancos I; Department of Internal Medicine, Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, MN, United States., Feelders RA; Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands., Kargi AY; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Miami, Miami, FL, United States., Kerr JM; Department of Endocrinology, Division of Endocrinology, Metabolism and Diabetes, University of Colorado Denver, Aurora, CO, United States., Gordon MB; Allegheny Neuroendocrinology Center, Allegheny General Hospital, Pittsburgh, PA, United States., Mariash CN; Methodist Research Institute, Indiana University School of Medicine, Indianapolis, IN, United States., Terzolo M; Department of Clinical and Biological Sciences, Internal Medicine 1 - San Luigi Gonzaga Hospital, University of Turin, Orbassano, Italy., Ellison N; Biostatistics, Trialwise, Inc, Houston, TX, United States., Moraitis AG; Drug Research and Development, Corcept Therapeutics, Menlo Park, CA, United States. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2021 Jul 14; Vol. 12, pp. 662865. Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021). |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2021.662865 |
